ENXTAM:DSFIRChemicals
DSM Firmenich (ENXTAM:DSFIR) Stock Valuation After Landmark FDA Approval For Parsol Shield
FDA approval of PARSOL Shield puts DSM-Firmenich (ENXTAM:DSFIR) in focus
DSM-Firmenich (ENXTAM:DSFIR) is drawing fresh attention after the U.S. FDA approved its sunscreen ingredient bemotrizinol, marketed as PARSOL Shield. This is the first new U.S. sunscreen active to be approved under modernized safety guidelines in over 25 years.
See our latest analysis for DSM-Firmenich.
At a share price of €73.8, DSM-Firmenich has seen strong short term momentum, with a 25.08% 90 day share price return...